CRIS Current Research Information System

MACCHINI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.260
NA - Nord America 3.110
EU - Europa 2.461
AF - Africa 224
SA - Sud America 191
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.065
VN - Vietnam 999
CN - Cina 837
SG - Singapore 803
IT - Italia 551
GB - Regno Unito 490
SE - Svezia 288
DE - Germania 262
HK - Hong Kong 173
FR - Francia 151
BR - Brasile 135
IN - India 134
RU - Federazione Russa 121
CH - Svizzera 111
UA - Ucraina 107
IE - Irlanda 92
NL - Olanda 76
KR - Corea 60
FI - Finlandia 57
JP - Giappone 56
ZA - Sudafrica 55
BD - Bangladesh 50
CI - Costa d'Avorio 44
TG - Togo 41
NG - Nigeria 37
EE - Estonia 35
AT - Austria 31
PH - Filippine 24
TH - Thailandia 22
BG - Bulgaria 21
SC - Seychelles 21
AR - Argentina 19
BE - Belgio 18
CA - Canada 18
JO - Giordania 16
ID - Indonesia 14
MX - Messico 14
PL - Polonia 12
TR - Turchia 11
PK - Pakistan 9
EC - Ecuador 8
ES - Italia 8
IR - Iran 8
CL - Cile 7
TW - Taiwan 7
HR - Croazia 6
CO - Colombia 5
DZ - Algeria 5
EG - Egitto 5
IQ - Iraq 5
LT - Lituania 5
NI - Nicaragua 5
PT - Portogallo 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
JM - Giamaica 4
NP - Nepal 4
PY - Paraguay 4
AU - Australia 3
CR - Costa Rica 3
GR - Grecia 3
KE - Kenya 3
PE - Perù 3
UY - Uruguay 3
BO - Bolivia 2
BY - Bielorussia 2
CM - Camerun 2
CZ - Repubblica Ceca 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BT - Bhutan 1
BW - Botswana 1
ET - Etiopia 1
KH - Cambogia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 9.251
Salva come PNG Salva come JPEG
Città #
Singapore 538
Southend 437
Ashburn 357
Chandler 237
Fairfield 208
Dong Ket 204
Hanoi 177
Ho Chi Minh City 175
Hong Kong 160
Santa Clara 160
San Jose 138
Princeton 118
New York 115
Houston 108
Bern 105
Beijing 103
Wilmington 101
Hefei 93
Dublin 92
Ann Arbor 91
Woodbridge 80
Boardman 75
Seattle 71
Dallas 68
Bologna 65
Lauterbourg 60
Jacksonville 58
Cambridge 57
Los Angeles 55
Helsinki 53
Seoul 51
Nanjing 49
Westminster 47
Padova 45
Abidjan 44
Rome 44
Tokyo 43
Lomé 41
Council Bluffs 36
Milan 36
Medford 35
Turin 34
Abeokuta 32
Berlin 30
Shenyang 29
Buffalo 27
Da Nang 26
Jinan 26
Frankfurt am Main 25
Florence 24
Guangzhou 24
Haiphong 24
Saint Petersburg 24
Redondo Beach 22
Sofia 21
Mülheim 20
Dearborn 19
Hebei 19
Shanghai 19
Changsha 18
Tianjin 18
Amman 16
Nanchang 15
Vienna 14
Brussels 13
Fremont 13
Hangzhou 13
Kyiv 13
Munich 13
Redwood City 13
São Paulo 13
Des Moines 12
Nuremberg 12
Orem 12
Ravenna 12
San Diego 12
Taiyuan 12
Falls Church 11
Jiaxing 11
Atlanta 10
Bến Tre 10
Hải Dương 10
San Francisco 10
Xi'an 10
Bangkok 9
Bengaluru 9
San Venanzo 9
Warsaw 9
Yubileyny 9
Zhengzhou 9
Brooklyn 8
Can Tho 8
Johannesburg 8
Kunming 8
Phoenix 8
Amsterdam 7
Chicago 7
Falkenstein 7
Haikou 7
Jakarta 7
Totale 5.720
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 461
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 272
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer 253
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 249
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 249
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 237
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 232
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 221
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 211
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 209
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 193
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 186
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 185
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 185
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs? 183
State of the art biological therapies in pancreatic cancer 180
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 177
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 173
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 172
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 166
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) 163
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 159
Erratum: β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer (Cancer Cell (2018) 33(1) (75–90.e7), (S153561081730510X) (10.1016/j.ccell.2017.11.007)) 159
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? 158
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE 156
Preoperatory Gemcitabine and Oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma 156
The follow-up issues: from the necessity to the opportunity 154
CIRCULATING METALLOPROTEINASE-3 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN PATIENTS WITH DUCTAL PANCREATIC NEOPLASMS 153
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 153
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 151
Whole Transcriptome Sequencing Reveals Molecular Prognostic Markers in Pancreatic Adenocarcinoma 151
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 149
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma. 148
Prognostic factors for recurrence in resected pancreatic adenocarcinoma: a single center experience 148
Whole-transcriptome paired-end sequencing and the pancreatic cancer genetic landscape 148
Hedgehog Signaling: from the Cuirass to the Heart of Pancreatic Cancer 144
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 144
Locally Advanced Pancreatic Cancer: Is It Possible Pancreatic Resection? A Case Report 143
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 142
Useful of Choi’s criteria after neoadjuvant chemoradiotherapy in patients with resectable pancreatic cancer. 140
Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma: An Interim Report of a Prospective Controlled Randomized Study 136
Long-Term Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Case Report 134
Prognostic factors in resected pancreatic cancer:a single centre experience 134
Whole genome discovery of genetic alterations carried by pancreatic adenocarcinoma 131
Whole Transcriptome Sequencing Reveals Somatic HMGCR Mutation in a Case of Pancreatic Adenocarcinoma with Long-Term Therapy Response 128
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer 127
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Resectable and Advanced Pancreatic Cancer. 120
New WHO classification for pancreatic endocrine tumours: is time to leave the previous one 118
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 114
SNP-Array High Resolution Cytogenetic Analysis of Resectable and Advanced Pancreatic Cancer 113
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: an interim report of a prospective controlled randomized study. 109
Whole genome discovery of genetic alterations in resectable and advanced pancreatic cancer. 106
Resection Margin Involvement in Pancreaticoduodenectomy. A Single Centre Experience 100
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 100
Role of CA 19-9 Concentration as an Independent Prognostic Factor in Unresectable Pancreatic Ductal Adenocarcinoma (PDCA) Treated with GemOx 97
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey 95
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 86
1517P Isolated LUng Metastases in pancreatic AdenoCArcinoma patients in a multicenter Italian cohort: The LU.M.A.CA study 80
Totale 9.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021362 0 0 0 0 0 0 0 0 0 0 0 362
2021/2022994 80 44 30 70 89 51 13 57 38 107 240 175
2022/20231.238 105 173 69 133 80 102 13 84 169 51 135 124
2023/2024405 26 44 10 37 34 135 17 31 9 21 23 18
2024/20251.251 59 136 98 66 232 56 112 87 25 95 47 238
2025/20263.365 278 282 273 232 323 172 438 106 715 293 139 114
Totale 9.441